Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
12/2003
12/18/2003US20030232824 Non-steroidal progesting
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232820 Method for synthesizing oxazinones
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003CA2488379A1 Selective chromophores
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/16/2003US6664411 Heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
12/16/2003US6664353 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
12/16/2003CA2248407C Thermally stable aminosulfur trifluorides
12/11/2003US20030229086 Central nervous system disorders; side effect reduction
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/09/2003US6660734 Oxazinones having antibacterial activity
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/04/2003WO2003099798A1 Morpholinylmethylureas ccr-3 receptor antagonist
12/04/2003WO2003099287A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2002086138A3 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225076 Mitogen ERK Kinase ("MEK") enzyme inhibitors
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367132A1 Process for preparation of optically active propoxyaniline derivatives
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/02/2003US6656936 Growth inhibitors of Candida albicans, and anti-HIV agents
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
11/2003
11/27/2003WO2003097618A1 Morpholinylmethylureas ccr-3 receptor antagonists
11/27/2003WO2002074735A3 Biurethane derivatives
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220268 New phenylalanine derivatives
11/27/2003US20030220196 Phenyl-substituted-2enamino-keto nitriles
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003050154A3 Catalytic carbonylation of three and four membered heterocycles
11/20/2003US20030216388 Cyclocarbamate derivatives as progesterone receptor modulators
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362845A2 New process for the synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and their use in the synthesis of perindopril
11/19/2003EP1208160B1 Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649610 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212062 Morpholinone and morpholine derivatives and uses thereof
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645960 Antifungal sordaricin derivatives
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090678A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003WO2003042195A3 Photochromic oxazine compounds and methods for their manufacture
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003US20030208070 Crystallization of efavirenz using mixtures of water and solvents such as 2-propanol
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003US20030206935 P-(alpha-hydroxyhydrocarbylcarbonylamino)-substituted benzoic acid esters; reducing and/or slowing down the loss of head hair and/or body hair, or inducing and/or stimulating its growth.
11/06/2003CA2483725A1 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003EP1359147A1 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and processes for making the same
11/05/2003CN1454206A 2-enamino-cetonitriles substitues par phenyle
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/30/2003WO2003089429A1 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
10/30/2003US20030203902 A 2-hydroxy-2-trifluoromethyl-valeroylamino benzotriazole, or benzo(1,2,5)thiadiazole, or benzo(1,2,5)oxadiazole derivatives; contraceptive agents, for treating endometriosis, gynecological disorders, male birth control
10/30/2003US20030202943 Nuclear magnetic resonance; medical diagnosis; diethylenetriaminepentaacetic acid monoamide
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003CN1452483A IL-8 receptor antagonists
10/28/2003US6639071 Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
10/28/2003US6639033 N-oxyl radicals
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638930 Morpholine and thiomorpholine tachykinin receptor antagonists
10/28/2003US6638713 Optical molecular sensors for cytochrome P450 activity
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/22/2003EP1200417B1 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 112